Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.

Susanto, Evelyn; Marin Navarro, Ana; Zhou, Leilei; Sundström, Anders; van Bree, Niek; Stantic, Marina; Moslem, Mohsen; Tailor, Jignesh; Rietdijk, Jonne; Zubillaga, Veronica; Hübner, Jens-Martin; Weishaupt, Holger; Wolfsberger, Johanna; Alafuzoff, Irina; Nordgren, Ann; Magnaldo, Thierry; Siesjö, Peter; Johnsen, John Inge; Kool, Marcel; Tammimies, Kristiina; Darabi, Anna; Swartling, Fredrik J; Falk, Anna; Wilhelm, Margareta

Medulloblastoma is the most common malignant brain tumor in children. Here we describe a medulloblastoma model using Induced pluripotent stem (iPS) cell-derived human neuroepithelial stem (NES) cells generated from a Gorlin syndrome patient carrying a germline mutation in the sonic hedgehog (SHH) receptor PTCH1. We found that Gorlin NES cells formed tumors in mouse cerebellum mimicking human medulloblastoma. Retransplantation of tumor-isolated NES (tNES) cells resulted in accelerated tumor formation, cells with reduced growth factor dependency, enhanced neurosphere formation in vitro, and increased sensitivity to Vismodegib. Using our model, we identified LGALS1 to be a GLI target gene that is up-regulated in both Gorlin tNES cells and SHH-subgroup of medulloblastoma patients. Taken together, we demonstrate that NES cells derived from Gorlin patients can be used as a resource to model medulloblastoma initiation and progression and to identify putative targets.